Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment

Molecular Nutrition and Food Research

Volumn 56, Issue 8, 2012, Pages 1247-1258

  Hu, Fang Wei ^a,b   Tsai, Lo Lin ^a,b   Yu, Chuan Hang ^a,b   Chen, Pei Ni ^a   Chou, Ming Yung ^a,b   Yu, Cheng Chia ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cancer Stem Cells; Epithelial mesenchymal transition; Head and neck cancer; Resveratrol; Tumor initiating cells

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 1; ANTINEOPLASTIC AGENT; HERMES ANTIGEN; ISOENZYME; RESVERATROL; RETINAL DEHYDROGENASE; STILBENE DERIVATIVE;

ANIMAL; APOPTOSIS; ARTICLE; CANCER STEM CELL; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; DRUG SCREENING; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GINGIVA; HEAD AND NECK TUMOR; HUMAN; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY;

ANIMALS; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL SURVIVAL; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GINGIVA; HEAD AND NECK NEOPLASMS; HUMANS; ISOENZYMES; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; RETINAL DEHYDROGENASE; STILBENES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84865140131     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200150     Document Type: Article

References (44)

1. Haddad, R. I., Shin, D. M., Recent advances in head and neck cancer. N. Engl. J. Med. 2008, 359, 1143-1154.
2. Siegel, R., Naishadham, D., Jemal, A., Cancer statistics, 2012. CA: A Cancer Journal for Clinicians 2012, 62, 10-29.
3. Feng, F. Y., Kim, H. M., Lyden, T. H., Haxer, M. J. et al., Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J. Clin. Oncol. 2010, 28, 2732-2738.
4. Prince, M. E., Sivanandan, R., Kaczorowski, A., Wolf, G. T. et al., Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 2007, 104, 973-978.
5. Chiou, S. H., Yu, C. C., Huang, C. Y., Lin, S. C. et al., Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin. Cancer Res. 2008, 14, 4085-4095.
6. Wu, M. J., Jan, C. I., Tsay, Y. G., Yu, Y. H. et al., Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling. Mol. Cancer 2010, 9, 283.1-16.
7. Lo, W. L., Yu, C. C., Chiou, G. Y., Chen, Y. W. et al., MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J. Pathol. 2011, 223, 482-495.
8. Lo, J. F., Yu, C. C., Chiou, S. H., Huang, C. Y. et al., The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Res. 2011, 71, 1912-1923.
9. Yu, C. C., Chen, Y. W., Chiou, G. Y., Tsai, L. L. et al., MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. Oral Oncol. 2011, 47, 202-210.
10. Chen, Y. S., Wu, M. J., Huang, C. Y., Lin, S. C. et al., CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer. PloS One 2011, 6, e28053.
11. Visus, C., Ito, D., Amoscato, A., Maciejewska-Franczak, M. et al., Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. Cancer Res. 2007, 67, 10538-10545.
12. Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F. et al., ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell stem cell 2007, 1, 555-567.
13. Ma, S., Chan, K. W., Lee, T. K., Tang, K. H. et al., Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol. Cancer Res. 2008, 6, 1146-1153.
14. Huang, E. H., Hynes, M. J., Zhang, T., Ginestier, C. et al., Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 2009, 69, 3382-3389.
15. Wang, L., Park, P., Zhang, H., La Marca, F. et al., Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity. Int. J. Cancer 2011, 128, 294-303.
16. Krishnamurthy, S., Dong, Z., Vodopyanov, D., Imai, A. et al., Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res. 2010, 70, 9969-9978.
17. Acloque, H., Adams, M. S., Fishwick, K., Bronner-Fraser, M. et al., Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J. Clin. Invest. 2009, 119, 1438-1449.
18. Polyak, K., Weinberg, R. A., Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature Rev. Cancer 2009, 9, 265-273.
19. Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N. et al., The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133, 704-715.
20. Chiou, S. H., Wang, M. L., Chou, Y. T., Chen, C. J. et al., Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 2010, 70, 10433-10444.
21. Smoliga, J. M., Baur, J. A., Hausenblas, H. A., Resveratrol and health - a comprehensive review of human clinical trials. Mol. Nutr. Food Res. 2011, 55, 1129-1141.
22. Ulrich, S., Wolter, F., Stein, J. M., Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis. Mol. Nutr. Food Res. 2005, 49, 452-461.
23. Pandey, P. R., Okuda, H., Watabe, M., Pai, S. K. et al., Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast cancer Res. Treat. 2011, 130, 387-398.
24. Castino, R., Pucer, A., Veneroni, R., Morani, F. et al., Resveratrol reduces the invasive growth and promotes the acquisition of a long-lasting differentiated phenotype in human glioblastoma cells. J. Agric. Food Chem. 2011, 59, 4264-4272.
25. Yang, Y. P., Chang, Y. L., Huang, P. I., Chiou, G. Y. et al., Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis. J. Cell. Physiol. 2012, 227, 976-993.
26. Shankar, S., Nall, D., Tang, S. N., Meeker, D. et al., Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PloS One 2011, 6, e16530.
27. Gupta, P. B., Chaffer, C. L., Weinberg, R. A., Cancer stem cells: mirage or reality? Nat. Med. 2009, 15, 1010-1012.
28. Yang, M. H., Hsu, D. S., Wang, H. W., Wang, H. J. et al., Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat. Cell Biol. 2010, 12, 982-992.
29. Rosen, J. M., Jordan, C. T., The increasing complexity of the cancer stem cell paradigm. Science 2009, 324, 1670-1673.
30. Li, Y., Wicha, M. S., Schwartz, S. J., Sun, D., Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds. J. Nutr. Biochem. 2011, 22, 799-806.
31. Kao, C. L., Huang, P. I., Tsai, P. H., Tsai, M. L. et al., Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor. Int. J. Radiat. Oncol. Biol. Phys. 2009, 74, 219-228.
32. Kotha, A., Sekharam, M., Cilenti, L., Siddiquee, K. et al., Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Mol. cancer Ther. 2006, 5, 621-629.
33. Kalluri, R., Weinberg, R. A., The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119, 1420-1428.
34. Gupta, P. B., Onder, T. T., Jiang, G., Tao, K. et al., Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009, 138, 645-659.
35. Tang, S. N., Singh, C., Nall, D., Meeker, D. et al., The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. J. Mol. Signal. 2010, 5, 14.1-15.
36. Kakarala, M., Brenner, D. E., Korkaya, H., Cheng, C. et al., Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res. Treat. 2010, 122, 777-785.
37. Li, Y., Zhang, T., Korkaya, H., Liu, S. et al., Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin. Cancer Res. 2010, 16, 2580-2590.
38. Lee, T. K., Castilho, A., Cheung, V. C., Tang, K. H. et al., Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation. Hepatology 2011, 53, 160-170.
39. Liu, C., Tang, D. G., MicroRNA regulation of cancer stem cells. Cancer Res. 2011, 71, 5950-5954.
40. Yu, F., Yao, H., Zhu, P., Zhang, X. et al., let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007, 131, 1109-1123.
41. Shimono, Y., Zabala, M., Cho, R. W., Lobo, N. et al., Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009, 138, 592-603.
42. Liu, C., Kelnar, K., Liu, B., Chen, X. et al., The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med. 2011, 17, 211-215.
43. Chiou, G. Y., Cherng, J. Y., Hsu, H. S., Wang, M. L. et al., Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma. J. Control. Release 2012, 159, 240-250.
44. Iliopoulos, D., Lindahl-Allen, M., Polytarchou, C., Hirsch, H. A. et al., Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol. Cell 2010, 39, 761-772.